Executive Profile

Robert T. Nelsen Co-founder and Managing Director, Arch Venture Partners, L.P.

Age	Total Calculated Compensation	This person is connected to 16 Board Members in 16 different organizations across 25 different industries. See Board Relationships
49	--

Background

Mr. Robert T. Nelsen, Bob is Co-Founder and Managing Director at ARCH Venture Partners, L.P. Mr. Nelsen focuses on alternative energy, biotechnology, and nanotechnology. Mr. Nelsen is associated with ARCH Venture since July 1994. From April 1987 to July 1994, he served as a Senior Manager at ARCH Development Corporation, where he was responsible for new company formation. Mr. Nelsen joined ARCH at its founding and has played a significant role in the early sourcing, ... financing, and development of more than 30 companies including nine which have reached valuations exceeding $1 billion. He serves as Board Observer of VLST Corporation. Mr. Nelsen has been a Director of Ikaria Inc. since April 2005, NeurogesX, Inc. since July 2000, Kythera BioPharmaceuticals, Inc since October 2010 and Xcyte Therapies Inc. since August 1996. Mr. Nelsen has been a Director at Syros Pharmaceuticals since April 11, 2013. He also serves as a Director of Sapphire Energy Inc, Fate Therapeutics, Inc., Agios Pharmaceuticals, Optobionics, Elixir, Ensemble Therapeutics, and Kilimanjaro Energy, Inc. Mr. Nelsen served as a Member at Genomica Corp.'s Board of Directors since 1997. He served on the Board of Directors at Caliper Technologies Corp. from September 1995 to February 2004. Mr. Nelsen served as a Director at Illumina Inc. since June 1998. He served as a Director at Accelerator Corporation and Surface Logix Inc. Mr. Nelsen served on the Boards at Theraclone, Trubion Pharmaceuticals, NetBot, Caliper Life Sciences, Everyday Learning, Spaltudaq, Array BioPharma, R2 Technology, and Classmates.com. Mr. Nelsen had been a Director at Adolor Corp. since inception in 1994. Mr. Nelsen served on the Board of Receptos, Inc. He also served on the Board at Fred Hutchinson Cancer Research Institute. He received an M.B.A. from the University of Chicago and a B.S. in Biology and Economics from the University of Puget Sound.

Corporate Headquarters 8725 West Higgins Road Chicago, Illinois 60631 United States Phone: 773-380-6600 Fax: 773-380-6606 Board Members Memberships member of the board Celebrate Express Inc. Director Everyday Learning Corporation Director GreaterGood.com, Inc. Director ImproveNet, Inc. Chairman Netbot, Inc. Director Optobionics Corporation Director Prizm Pharmaceuticals Director GoCampus, Inc. Former Director Surface Logix, Inc. Former Director Converge Medical, Inc. Former Director Elixir Pharmaceuticals, Inc. Former Director Alnylam Pharmaceuticals, Inc. Director Ares Bioscience GmbH Director National Venture Capital Association Member of Board of Directors Accelerator Corporation Former Director, Chairman of Compensation Committee and Chairman of Stock Option Committee Emergent Product Development Seattle, LLC Director Nura Inc. Director Ensemble Therapeutics Corporation Director Homestead Clinical Corporation Trustee Fred Hutchinson Cancer Research Center Director Fate Therapeutics, Inc. Director Sapphire Energy, Inc. Director Agios Pharmaceuticals, Inc. Former Director Receptos, Inc. Director Kilimanjaro Energy, Inc. 1994-2008 Former Director and Member of Compensation Committee Adolor Corporation 1995-2004 Former Director Caliper Life Sciences, Inc. 1996-N/A Former Director, Chairman of Compensation Committee and Chairman of Stock Option Committee Xcyte Therapies Inc. 1997-N/A Former Director Genomica Corp. 1998-N/A Former Director Illumina Inc. 2000-Present Independent Director and Member of Compensation Committee NeurogesX, Inc. 2005-Present Director and Member of Nominating & Governance Committee Ikaria, Inc. 2006-Present Director Kythera Biopharmaceuticals, Inc. 2013-Present Director Syros Pharmaceuticals, Inc. Education MBA The University of Chicago BS University of Puget Sound Unknown/Other Education Loyola University of Chicago Unknown/Other Education The University of Chicago Booth School of Business Other Affiliations Adolor Corporation Celebrate Express Inc. Caliper Life Sciences, Inc. Everyday Learning Corporation Genomica Corp. GreaterGood.com, Inc. Illumina Inc. ImproveNet, Inc. Netbot, Inc. Optobionics Corporation Prizm Pharmaceuticals GoCampus, Inc. The University of Chicago ARCH Development Partners, L.L.C. Surface Logix, Inc. NeurogesX, Inc. Converge Medical, Inc. Elixir Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Loyola University of Chicago Chiasma (Israel) Ltd. ARCH Venture Fund V, L.P. Ares Bioscience GmbH University of Puget Sound ARCH Venture Fund VI, L.P. National Venture Capital Association Accelerator Corporation The University of Chicago Booth School of Business Xcyte Therapies Inc. Emergent Product Development Seattle, LLC Nura Inc. Ensemble Therapeutics Corporation VLST Corporation Ikaria, Inc. Homestead Clinical Corporation Kythera Biopharmaceuticals, Inc. Fred Hutchinson Cancer Research Center Fate Therapeutics, Inc. Sapphire Energy, Inc. Agios Pharmaceuticals, Inc. Receptos, Inc. Kilimanjaro Energy, Inc. Syros Pharmaceuticals, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.